An2 Therapeutics, Inc. · NASDAQ:ANTX
Millennium Management LLC reported a 6.30% stake in An2 Therapeutics, Inc. (Schedule 13G)
Event Mar 6, 2026 · Filed Mar 13, 2026
Millennium Management LLC reported a 6.30% stake in An2 Therapeutics, Inc., 2,237,102 shares, as a passive investor on Mar 6, 2026. Filed Mar 13, 2026 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 2,237,102
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 6.00% | 2,135,044 |
| Millennium Management LLC | 6.30% | 2,237,102 |
| Millennium Group Management LLC | 6.30% | 2,237,102 |
| Israel A. Englander | 6.30% | 2,237,102 |